Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson diseaseFabrizio Stocchi, David Hewitt, Anjela Tzontcheva et al.|Neurology|2017Cited by 67
Phase-3 Clinical Trial of the Adenosine 2a Antagonist Preladenant, Given as Monotherapy, in Patients with Parkinson’s Disease (S7.004)Fabrizio Stocchi, David Hewitt, Olivier Rascol et al.|Neurology|2014Cited by 6